Literature DB >> 16430863

Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy.

Elena Gennaro1, Filippo M Santorelli, Enrico Bertini, Daniela Buti, Roberto Gaggero, Giuseppe Gobbi, Marcella Lini, Tiziana Granata, Elena Freri, Antonia Parmeggiani, Pasquale Striano, Pierangelo Veggiotti, Simona Cardinali, Franca Dagna Bricarelli, Carlo Minetti, Federico Zara.   

Abstract

Severe Myoclonic Epilepsy in Infancy (SMEI) is an intractable epileptic syndrome with onset in the first year of life and is commonly caused by de novo mutations in the SCN1A gene, encoding the alpha1-subunit of the neuronal voltage-gated sodium channel. We report two unrelated families in which probands were affected by SMEI and their parents showed a single febrile seizure during early childhood or no neurological symptoms. Semiquantitative analysis of SCN1A mutations allowed the detection of a somatic and germline mosaicism in one of the parents. The study provides the first example of parental mosaicisms in SMEI and opens a new insight into the phenotypic variability and complex inheritance of this condition. The identification of germline mosaicisms has important consequences in genetic counseling of SMEI when SCN1A mutations appear to occur de novo with standard screening methods.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16430863     DOI: 10.1016/j.bbrc.2005.12.209

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

Review 1.  The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients.

Authors:  Davide Mei; Elena Parrini; Carla Marini; Renzo Guerrini
Journal:  Mol Diagn Ther       Date:  2017-08       Impact factor: 4.074

Review 2.  The genetics of the epilepsies.

Authors:  Christelle M El Achkar; Heather E Olson; Annapurna Poduri; Phillip L Pearl
Journal:  Curr Neurol Neurosci Rep       Date:  2015-07       Impact factor: 5.081

Review 3.  Sodium channel SCN1A and epilepsy: mutations and mechanisms.

Authors:  Andrew Escayg; Alan L Goldin
Journal:  Epilepsia       Date:  2010-09       Impact factor: 5.864

Review 4.  Somatic mutation, genomic variation, and neurological disease.

Authors:  Annapurna Poduri; Gilad D Evrony; Xuyu Cai; Christopher A Walsh
Journal:  Science       Date:  2013-07-05       Impact factor: 47.728

5.  Recessive loss-of-function mutations in AP4S1 cause mild fever-sensitive seizures, developmental delay and spastic paraplegia through loss of AP-4 complex assembly.

Authors:  Katia Hardies; Patrick May; Tania Djémié; Oana Tarta-Arsene; Tine Deconinck; Dana Craiu; Ingo Helbig; Arvid Suls; Rudy Balling; Sarah Weckhuysen; Peter De Jonghe; Jennifer Hirst
Journal:  Hum Mol Genet       Date:  2014-12-30       Impact factor: 6.150

6.  De novo mutations of voltage-gated sodium channel alphaII gene SCN2A in intractable epilepsies.

Authors:  I Ogiwara; K Ito; Y Sawaishi; H Osaka; E Mazaki; I Inoue; M Montal; T Hashikawa; T Shike; T Fujiwara; Y Inoue; M Kaneda; K Yamakawa
Journal:  Neurology       Date:  2009-09-29       Impact factor: 9.910

Review 7.  Genetic basis in epilepsies caused by malformations of cortical development and in those with structurally normal brain.

Authors:  Danielle M Andrade
Journal:  Hum Genet       Date:  2009-06-18       Impact factor: 4.132

8.  Gonadal mosaicism and familial adenomatous polyposis.

Authors:  Angela L Schwab; Thérèse M F Tuohy; Michelle Condie; Deborah W Neklason; Randall W Burt
Journal:  Fam Cancer       Date:  2007-11-18       Impact factor: 2.375

Review 9.  Channelopathies in idiopathic epilepsy.

Authors:  Sarah E Heron; Ingrid E Scheffer; Samuel F Berkovic; Leanne M Dibbens; John C Mulley
Journal:  Neurotherapeutics       Date:  2007-04       Impact factor: 7.620

Review 10.  The hidden genetics of epilepsy-a clinically important new paradigm.

Authors:  Rhys H Thomas; Samuel F Berkovic
Journal:  Nat Rev Neurol       Date:  2014-04-15       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.